Differentiation between naproxen, naproxen-protein conjugates, and naproxen-lysine in plasma via micellar electrokinetic capillary chromatography - A new approach in the bioanalysis of drug targeting preparations

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2083-2090

  Albrecht, Christiane ^a   Reichen, Jürg ^a   Visser, Jan ^b   Meijer, Dirk K F ^b   Thormann, Wolfgang ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOLICHOL PHOSPHATE MANNOSE; DRUG CARRIER; LYSINE; NAPROXEN; SERUM ALBUMIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CAPILLARY CHROMATOGRAPHY; DIAGNOSTIC ACCURACY; DRUG TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICELLE;

EID: 0030726013     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2083     Document Type: Article

References (24)

1. Meijer DKF, Molema G. Targeting of drugs to the liver. Semin Liver Dis 1995;15:203-56.
2. Franssen EJF, Jansen RW, Vaalburg M, Meijer DKF. Hepatic and intrahepatic targeting of an antiinflammatory agent with human serum albumin and neoglycoproteins as carrier molecules. Biochem Pharmacol 1993;45:1215-26.
3. Lebbe C, Reichen J, Wartna E, Sägesser H, Poelstra K, Meijer DKF. Targeting naproxen to non parenchymal liver cells protects against endotoxin induced liver damage. J Drug Target 1997;4:303-10.
4. Albrecht C, Meijer DKF, Sägesser H, Reichen J. Naproxen targeted to endothelial and Kupffer cells protects against endotoxin in biliary cirrhosis in the rat. J Hepatol 1996;25(Suppl 1):130.
5. Karidas T, Avgerinos A, Malamataris S. Extractionless HPLC method for the determination of naproxen in human plasma and urine. Anal Lett 1993;26:2341-8.
6. Singh AK, Jang Y, Mishra U, Granley K. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography -mass spectrometry. J Chromatogr 1991;568:351-61.
7. Andersen JV, Hansen SH. Simultaneous determination of (R)- and (S)-naproxen and (R)- and (S)-6-O-desmethylnaproxen by high-performance liquid chromatography on a chiral-AGP column. J Chromatogr 1992;577:362-5.
8. Blagbrough IS, Daykin MM, Doherty M, Pattrick M, Shaw PN. High performance liquid chromatographic determination of naproxen, ibuprofen and diclofenac in plasma and synovial fluid in man. J Chromatogr 1992;578:251-7.
9. Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CPWGM. Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography. J Chromatogr 1992;578:239-49.
10. Andersen JV, Hansen SH. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica. J Chromatogr 1992;577:325-33.
11. Shimek JL, Rao NGS, Wahba Khalil SK. An isocratic high-pressure liquid chromatographic determination of naproxen and desmethylnaproxen in human plasma. J Pharm Sci 1982;71:436-9.
12. Soini H, Novotny MV, Riekkola M-L. Determination of naproxen in serum by capillary electrophoresis with ultraviolet absorbance and laser-induced fluorescence detection. J Microcol Sep 1992;4: 313-8.
13. Zhang C-X, Thormann W. Determination of drug levels in human serum by micellar electrokinetic capillary chromatography with direct sample injection using different quantitation strategies. J Capillary Electrophor 1994;1:208-18.
14. Caslavska J, Gassmann E, Thormann W. Modification of a tunable UV-visible capillary electrophoresis detector for simultaneous absorbance and fluorescence detection: profiling of body fluids for drugs and endogenous compounds. J Chromatogr A 1995;709: 147-56.
15. Schmutz A, Thormann W. Assessment of impact of physicochemical drug properties on monitoring drug levels by micellar electrokinetic capillary chromatography with direct serum injection. Electrophoresis 1994;15:1295-303.
16. Steinmann L, Thormann W. Characterization of competitive binding, fluorescent drug immunoassays based on micellar electrokinetic capillary chromatography. Electrophoresis 1996;17:1348-56.
17. Thormann W, Zhang C-X, Schmutz A. Capillary electrophoresis for drug analysis in body fluids. Ther Drug Monit 1996;18:506-20.
18. Franssen EJF, Koiter J, Kuipers CAM, Bruins AP, Moolenaar F, de Zeeuw D, et al. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenstes and lysosomal lysates. J Med Chem 1992;35:1246-59.
19. Franssen EJF, van Amsterdam RGM, Visser J, Moolenaar F, de Zeeuw D, Meijer DKF. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme. Pharm Res 1991;8: 1223-30.
20. Grolleman CWJ, Visser AC, Wolke JGC, Timmerman H. Studies on a bioerodable drug carrier system based on polyphosphazene. Part 1. Synthesis. J Contr Rel 1986;3:143.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;93:265-75.
22. Habeeb AFSA. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966;14:328-36.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
24. Thormann W. Drug monitoring by capillary electrophoresis. In: Wong SHY, Sunshine I, eds. Handbook of analytical therapeutic drug monitoring and toxicology. Boca Raton, FL: CRC Press, 1997:1-19.